The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

In a move to make the relationship between the FDA and the outside advisors more transparent, the FDA will require them to disclose potential financial conflicts of interest in writing. In 2006, a study found that a quarter of all experts the FDA relied on for advice on drugs, including whether or not to approve them for public use, had a financial conflict of interest. The proposed changes come on the heels of Congressional investigations into potential conflicts of interest with the drugs Avandia and Ketek.

For more information on this subject, please refer to the section on Drugs, Medical Devices and Implants.

Comments are closed.

Of Interest